PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Qiagen N.V. (QGEN)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

NL0012169213

CUSIP

001216921

Sector

Healthcare

IPO Date

Jun 28, 1996

Highlights

Market Cap

$8.48B

EPS (TTM)

$0.38

PE Ratio

103.21

PEG Ratio

0.90

Total Revenue (TTM)

$1.46B

Gross Profit (TTM)

$631.34M

EBITDA (TTM)

$171.37M

Year Range

$39.02 - $47.96

Target Price

$50.42

Short %

1.54%

Short Ratio

2.29

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
QGEN vs. SPY QGEN vs. DLB
Popular comparisons:
QGEN vs. SPY QGEN vs. DLB

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Qiagen N.V., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-15.00%-10.00%-5.00%0.00%5.00%10.00%SeptemberOctoberNovemberDecember2025February
-16.71%
9.31%
QGEN (Qiagen N.V.)
Benchmark (^GSPC)

Returns By Period

Qiagen N.V. had a return of -11.98% year-to-date (YTD) and -8.42% in the last 12 months. Over the past 10 years, Qiagen N.V. had an annualized return of 4.82%, while the S&P 500 had an annualized return of 11.31%, indicating that Qiagen N.V. did not perform as well as the benchmark.


QGEN

YTD

-11.98%

1M

-14.80%

6M

-16.71%

1Y

-8.42%

5Y*

0.92%

10Y*

4.82%

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of QGEN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20250.18%-11.98%
20240.37%-1.99%0.47%-1.54%2.20%-5.02%8.27%2.74%-0.31%-7.61%3.16%2.53%2.37%
2023-1.74%-6.22%-0.04%-2.87%1.23%-0.29%3.98%-2.84%-10.97%-7.58%9.97%5.52%-12.91%
2022-10.96%0.40%-1.39%-7.41%1.28%2.72%5.17%-8.48%-9.14%5.52%13.73%0.67%-10.27%
20212.46%-7.66%-2.62%-1.15%2.56%-1.99%9.12%5.74%-7.42%7.89%-1.13%0.82%5.17%
2020-0.06%6.28%15.88%0.22%5.04%-2.24%15.51%3.05%2.55%-9.22%1.73%9.51%56.36%
20197.49%3.78%5.85%-4.23%-2.26%6.49%-6.98%-8.03%-4.96%-9.58%43.58%-21.03%-1.89%
20188.28%0.63%-4.12%1.24%11.01%-0.41%-0.11%7.89%-2.80%-4.17%-2.37%-2.79%11.38%
20173.43%-1.79%1.79%3.87%11.53%-0.09%-2.06%-2.04%-2.08%7.49%-5.79%-3.04%10.39%
2016-17.87%-7.05%5.83%0.54%-3.92%1.07%22.88%-1.08%3.51%-11.15%12.06%2.56%1.34%
2015-2.26%10.16%-0.24%-5.52%3.17%0.92%12.87%-6.29%-1.60%-6.32%9.39%4.58%17.86%
2014-7.10%0.59%-5.21%3.84%4.84%6.49%-0.08%-1.08%-5.77%3.03%2.00%-1.96%-1.47%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of QGEN is 24, meaning it’s performing worse than 76% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of QGEN is 2424
Overall Rank
The Sharpe Ratio Rank of QGEN is 2727
Sharpe Ratio Rank
The Sortino Ratio Rank of QGEN is 2222
Sortino Ratio Rank
The Omega Ratio Rank of QGEN is 2424
Omega Ratio Rank
The Calmar Ratio Rank of QGEN is 3030
Calmar Ratio Rank
The Martin Ratio Rank of QGEN is 1616
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Qiagen N.V. (QGEN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for QGEN, currently valued at -0.37, compared to the broader market-2.000.002.00-0.371.74
The chart of Sortino ratio for QGEN, currently valued at -0.39, compared to the broader market-4.00-2.000.002.004.006.00-0.392.35
The chart of Omega ratio for QGEN, currently valued at 0.96, compared to the broader market0.501.001.502.000.961.32
The chart of Calmar ratio for QGEN, currently valued at -0.26, compared to the broader market0.002.004.006.00-0.262.61
The chart of Martin ratio for QGEN, currently valued at -1.18, compared to the broader market0.0010.0020.0030.00-1.1810.66
QGEN
^GSPC

The current Qiagen N.V. Sharpe ratio is -0.37. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Qiagen N.V. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.37
1.74
QGEN (Qiagen N.V.)
Benchmark (^GSPC)

Dividends

Dividend History

Qiagen N.V. provided a 3.21% dividend yield over the last twelve months, with an annual payout of $1.26 per share.


0.00%0.50%1.00%1.50%2.00%2.50%3.00%3.50%$0.00$0.20$0.40$0.60$0.80$1.00$1.20$1.4020172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017
Dividend$1.26$1.32$0.00$0.00$0.00$0.00$0.00$0.00$1.09

Dividend yield

3.21%2.88%0.00%0.00%0.00%0.00%0.00%0.00%3.31%

Monthly Dividends

The table displays the monthly dividend distributions for Qiagen N.V.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$1.26$0.00$1.26
2024$1.32$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.32
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2020$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2018$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2017$1.09$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.09

Dividend Yield & Payout


Dividend Yield
200.0%400.0%600.0%3.2%
Qiagen N.V. has a dividend yield of 3.21%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%1,000.0%57.5%
Qiagen N.V. has a payout ratio of 57.53%, which is quite average when compared to the overall market. This suggests that Qiagen N.V. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-31.44%
0
QGEN (Qiagen N.V.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Qiagen N.V.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Qiagen N.V. was 92.14%, occurring on Oct 4, 2002. The portfolio has not yet recovered.

The current Qiagen N.V. drawdown is 31.44%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-92.14%Jul 18, 2000556Oct 4, 2002
-47.3%Mar 13, 200017Apr 4, 200071Jul 17, 200088
-36.92%Mar 23, 1998140Oct 9, 199882Feb 8, 1999222
-35.17%Jul 15, 199774Oct 27, 199794Mar 13, 1998168
-24.4%Oct 14, 199616Nov 4, 199684Mar 6, 1997100

Volatility

Volatility Chart

The current Qiagen N.V. volatility is 8.35%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%SeptemberOctoberNovemberDecember2025February
8.35%
3.07%
QGEN (Qiagen N.V.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Qiagen N.V. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Qiagen N.V. compared to its peers in the Diagnostics & Research industry.


PE Ratio
100.0200.0300.0400.0500.0103.2
The chart displays the price to earnings (P/E) ratio for QGEN in comparison to other companies of the Diagnostics & Research industry. Currently, QGEN has a PE value of 103.2. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.
PEG Ratio
-2.00.02.04.00.9
The chart displays the price to earnings to growth (PEG) ratio for QGEN in comparison to other companies of the Diagnostics & Research industry. Currently, QGEN has a PEG value of 0.9. This PEG ratio falls in the average range for the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Qiagen N.V..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab